Agilent Technologies (NYSE:A) Releases FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 5.540-5.610 for the period, compared to the consensus earnings per share estimate of 5.570. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its Q2 2025 guidance to 1.250-1.280 EPS.

Agilent Technologies Trading Down 4.4 %

Shares of A stock traded down $5.91 on Thursday, reaching $128.56. 860,993 shares of the company’s stock were exchanged, compared to its average volume of 1,652,657. The company’s fifty day simple moving average is $140.90 and its 200 day simple moving average is $139.28. Agilent Technologies has a 52 week low of $124.16 and a 52 week high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $36.68 billion, a PE ratio of 29.12, a P/E/G ratio of 3.63 and a beta of 1.07.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. As a group, analysts forecast that Agilent Technologies will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.77%. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on A shares. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Wells Fargo & Company lowered their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Citigroup increased their price target on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Finally, Robert W. Baird dropped their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $146.15.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.